RECBIO
Focusing on major innovative vaccines with independent intellectual property rights.
RECBIO
Industry:
Health Care Life Science
Founded:
2012-01-01
Address:
Taizhou, Jiangsu, China
Country:
China
Website Url:
http://www.recbio.cn
Status:
Active
Contact:
0523-86818860
Total Funding:
382.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Mobile Non Scaleable Content Euro IPv6 COVID-19 Pound Sterling
Current Employees Featured
Founder
Stock Details
Investors List
Legend Capital
Legend Capital investment in Series C - RecBio
LYFE Capital
LYFE Capital investment in Series C - RecBio
Temasek Holdings
Temasek Holdings investment in Series C - RecBio
E Fund Management Co.,LTD.
E Fund Management Co.,LTD. investment in Series C - RecBio
Boyu Capital
Boyu Capital investment in Series C - RecBio
Lake Bleu Capital
Lake Bleu Capital investment in Series C - RecBio
Sequoia Capital China
Sequoia Capital China investment in Series C - RecBio
HT Capital
HT Capital investment in Series B - RecBio
China Everbright Investment Management
China Everbright Investment Management investment in Series B - RecBio
Qingsong Fund
Qingsong Fund investment in Series B - RecBio
Official Site Inspections
http://www.recbio.cn Semrush global rank: 6.26 M Semrush visits lastest month: 1.22 K
- Host name: 39.105.246.98
- IP address: 39.105.246.98
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "RecBio"
江苏瑞科生物技术股份有限公司
江苏瑞科生物技术股份有限公司（以下简称“瑞科生物”或“公司”，香港联交所股票代码：02179）始创于2012年，是一家以自主研发技术为核心驱动力的创新型疫苗公司。 公司始终秉持“创制一 …See details»
About Us - Recbio
Committed to our mission of " Protect human health with best-in-class vaccines", we have cultivated a robust portfolio of vaccine products with exclusive rights, addressing the …See details»
Recbio
Jiangsu Recbio Biotechnology Co., LTD. ( "Recbio" or "Company", Stock Code: 02179.HK) which founded in 2011, is an innovative vaccine company with independent research and development technology as the core driving force.See details»
Recbio - LinkedIn
Recbio (HKEX:02179) is an innovative vaccine company founded in 2012. With the vision of "Become the Leader of Innovative Vaccine in the Future," Recbio takes "Protect Human Health with...See details»
RecBio - Crunchbase Company Profile & Funding
Recbio, founded in 2012, is an innovative vaccine company based on independent research and development technology. It is dedicated to establishing a full value chain for innovative vaccines, including research and …See details»
RecBio Company Profile - Office Locations, Competitors, Revenue …
RecBio is a biotech company that develops and commercializes genetically engineered vaccines for major diseases. It offers such products as human papillomavirus vaccines, recombinant …See details»
Jiangsu Recbio Technology Co., Ltd. - synapse.zhihuiya.com
10月23日，瑞科生物发布公告，公司自主研发的新佐剂重组带状疱疹疫苗REC610，已于近日正式启动中国III期临床研究并完成首批受试者入组。 中国III期临床研究采用随机、双盲、安慰剂对 …See details»
Jiangsu Recbio Technology Co., Ltd. announced 2023 annual …
Mar 20, 2024 · Founded in 2012, Jiangsu Recbio Technology Co., Ltd. (hereafter referred to as Recbio or the Company; stock code: 2179.HK) is an innovative vaccine company propelled by …See details»
关于瑞科 - Recbio
江苏瑞科生物技术股份有限公司（以下简称“瑞科生物”或“公司”，香港联交所股票代码：02179）始创于2012年，是一家以自主研发技术为核心驱动力的创新型疫苗公司。 公司始终秉持“创制一 …See details»
Recbio Receives Pharmaceutical Production License from Jiangsu …
Nov 17, 2021 · Recbio is one of the few companies with commercial production capability for novel adjuvants that have been approved by FDA for human use. Thanks to that, vaccines …See details»
Recbio and Rhegen Signed an mRNA Vaccine Cooperation …
Sep 29, 2021 · Recbio is an innovative vaccine company founded in 2012. With the vision of "Become the Leader of Innovative Vaccine in the Future," Recbio takes "Protect Human …See details»
Recbio Announces Promising Preliminary Results From First-in …
Nov 12, 2021 · Recbio is an innovative vaccine company founded in 2012. With the vision of "Become the Leader of Innovative Vaccine in the Future," Recbio takes "Protect Human …See details»
Recbio and Rhegen Signed an mRNA Vaccine Cooperation …
Sep 29, 2021 · The core scientific team has more than 20 years of experience in the development and commercialization of innovative vaccines. For more information, please visit …See details»
Clinical Trial Approval For ReCOV In The PRC And The Overseas
ReCOV is a recombinant COVID-19 vaccine being developed by the Group with its technology platforms including the novel adjuvant and protein engineering platforms. Based on the …See details»
Recbio Provides Updates on First Lyophilized mRNA Vaccine and …
Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data of its …See details»
Recbio Provides Updates on First Lyophilized mRNA Vaccine
TAIZHOU, China, Feb. 14, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major …See details»
中国注册会计师协会-通知公告
1 day ago · 经财政部注册会计师考试委员会批准，现将202 5 年注册会计师全国统一考试报名时间和考试时间公告如下：. 一、报名时间. 202 5 年4月8日 早 8:00 —4月30日 晚8:00 。. 二、交 …See details»
Recbio Provides Updates on First Lyophilized mRNA Vaccine and …
TAIZHOU, China, Feb. 14, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (Recbio), a China -based company focused on the development of innovative vaccines for major …See details»
Recbio Announces Promising Preliminary Results From First-in …
Jiangsu Recbio Technology Co., Ltd. ("Recbio"), a biopharmaceutical company focusing on the research, development and commercialization of innovative vaccines that can address …See details»
Recbio Announces New Study Showing Its COVID-19 Vaccine …
Nov 9, 2021 · Recbio is an innovative vaccine company founded in 2012. With the vision of "Become the Leader of Innovative Vaccine in the Future," Recbio takes "Protect Human …See details»